Assay
Financial-condition grades for SEC filers
Company Report · as of Oct 9, 2026
|
| cbdMD, Inc.YCBD · chemicals | |
|---|---|
| Grade |  Eweakest fifth of 331 graded peers; percentile 86.7, sampling error 2.7 points; lower is stronger |
| Rank | 282 of 331 |
| Profitability | Bpercentile 28.3 |
| Solvency | Dpercentile 76.6 |
| Growth and financing | Epercentile 97.6 |
| Reliability | 0.76 AUCfailure model, filers with under $12.5M assets; 95% interval 0.65 to 0.86; 63 events, 2020 to 2025 |
| Peer failure rate | 0.60% a yearItem 1.03 bankruptcies, same asset band, 2012 to 2025 |
| Size band | under $12.5M assetstotal assets $10.4M[1] |
| Standard universe | insiderevenue above $1M and assets above $10M[1-2] |
| Warnings | none activenot computable: dilution, distress, fortress balance sheet |
| Inputs computable | 7 of 14 |
| Graded from | filings received through Jan 20, 2026262 days before the rescan; every figure keyed to the SEC receipt date |
| Last close | $0.392026-10-08; market equity $4.4M; iex feed |
| Price used in grade | None |
| Share price, twelve months to the rescansplit-adjusted close; a lollipop at every rescan carries the letter held then; baseline ticks are SEC receipt dates of the inputs; ranges and dragging scroll the full history | ||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Percentile at every rescan on file, Jan 21, 2012 to Oct 9, 2026; stronger toward the top. Hover for the date. Open this report as it stood on | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Each date opens the report as it stood on that rescan. |
Business, in the company's words. Opening of Item 1 of the 10-K received Dec 19, 2025; the document on sec.gov.
cbdMD, Inc. is a consumer wellness company focused on the development, manufacturing, marketing, and sale of supplement brands powered by natural compounds. The majority of our products are anchored by hemp-derived cannabinoids, including broad-spectrum and full-spectrum CBD formulations, hemp-derived Delta-9 THC products (where permitted by law), and a range of functional products designed to address key wellness needs such as sleep, recovery, mood, discomfort, mobility, cognitive function, and stress management.
The Fourteen Inputs [top]
Lower percentile is stronger. Source numbers open the SEC filing; a range that spans filings opens the sources table.
| Input | Percentile, 0 to 100 | Value | Source | Peer median | Percentile | Peers | Period end |
|---|---|---|---|---|---|---|---|
| Profitability, sleeve percentile 28.3 | |||||||
| Gross profitability | 114.9% | [1,3] | 21.3% | 0.3 | 359 | 2025-09-30 | |
| Return on invested capital | not computable | 9.5% | |||||
| one or more required annual facts are missing | |||||||
| Accruals ratio | (5.6%) | [1,4-6] | (4.2%) | 38.6 | 400 | 2025-09-30 | |
| Gross margin stability, five years | 2.1 pts | [2-3,7-14] | 2.2 pts | 46.0 | 301 | 2025-09-30 | |
| Solvency, sleeve percentile 76.6 | |||||||
| Twelve-month failure probability | not computable | 0.05% | |||||
| latest liabilities, cash plus short-term investments, book equity, and shares are required | |||||||
| Altman Z double-prime | (53.04) | [1,15-20] | 3.41 | 99.0 | 301 | 2025-09-30 | |
| Net debt to EBITDA | not computable | 1.88x | |||||
| one or more required annual facts are missing | |||||||
| Interest coverage | not computable | 4.16x | |||||
| interest expense must exceed $100,000 | |||||||
| Current ratio | 2.05x | [15-16] | 2.20x | 54.3 | 423 | 2025-09-30 | |
| Growth and financing, sleeve percentile 97.6 | |||||||
| Revenue growth, three-year compound | (18.5%) | [2,8,10,12] | 1.2% | 96.3 | 350 | 2025-09-30 | |
| Free cash flow growth, three-year compound | not computable | 12.6% | |||||
| current FCF must be positive and base FCF must exceed $100,000 | |||||||
| Reinvestment rate | not computable | 24.3% | |||||
| NOPAT must exceed $100,000 | |||||||
| Asset growth, three years | (36.6%) | [1,6,21-22] | 2.9% | 98.9 | 369 | 2025-09-30 | |
| Net share issuance, one year | not computable | 0.0% | |||||
| prior share count is 31 days earlier | |||||||
Gross profitability. Revenue less cost of goods sold, over total assets.
Accruals ratio. Net income less operating cash flow, over average assets; lower is stronger.
Gross margin stability, five years. Standard deviation of gross margin; lower is stronger.
Twelve-month failure probability. CHS model; lower is stronger.
Net debt to EBITDA. Lower is stronger.
Net share issuance, one year. Split-adjusted; lower is stronger.
Sleeves are equal-weighted; within a sleeve each computable input carries equal weight. Composite 0.363; sampling error 2.7 percentile points on 331 peers.
Among 331 Peers [top]
Composite score of every graded peer, smoothed. Vertical rules are the letter band edges at the 20th, 40th, 60th and 80th percentiles. Small dots are the six largest peers by market equity.
| Rank | Company | Percentile | Letter | Warnings |
|---|---|---|---|---|
| 277 | Stepan Co. (SCL) Stepan Co. (SCL) Eweakest fifth; percentile 85.8 NYSE · Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics market equity $1.4B; last close $60.95 No active warnings; 10 of 14 inputs | 85.8 | E | |
| 278 | Smurfit Westrock plc (SW) Smurfit Westrock plc (SW) Eweakest fifth; percentile 85.8 NYSE · Paperboard Containers & Boxes market equity $21.7B; last close $41.45 No active warnings; 8 of 14 inputs | 85.8 | E | |
| 279 | FMC Corp. (FMC) FMC Corp. (FMC) Eweakest fifth; percentile 86.1 NYSE · Chemicals & Allied Products market equity $1.1B; last close $8.91 No active warnings; 7 of 14 inputs | 86.1 | E | |
| 280 | Worthington Enterprises, Inc. (WOR) Worthington Enterprises, Inc. (WOR) Eweakest fifth; percentile 86.2 NYSE · Steel Works, Blast Furnaces & Rolling & Finishing Mills market equity $3.0B; last close $61.13 No active warnings; 13 of 14 inputs | 86.2 | E | |
| 281 | IT Tech Packaging, Inc. (ITP) IT Tech Packaging, Inc. (ITP) Eweakest fifth; percentile 86.6 NYSE · Converted Paper & Paperboard Prods (No Contaners/Boxes) market equity $2.5M; last close $0.15 Warnings: late filer, fortress balance sheet; 9 of 14 inputs | 86.6 | E | late filer, fortress balance sheet |
| 282 | cbdMD, Inc. (YCBD) cbdMD, Inc. (YCBD) Eweakest fifth; percentile 86.7 NYSE · Perfumes, Cosmetics & Other Toilet Preparations market equity $4.4M; last close $0.39 No active warnings; 7 of 14 inputs | 86.7 | E | |
| 283 | Matthews International Corp. (MATW) Matthews International Corp. (MATW) Eweakest fifth; percentile 87.0 Nasdaq · Nonferrous Foundries (Castings) market equity $602.7M; last close $19.32 No active warnings; 9 of 14 inputs | 87.0 | E | |
| 284 | LSB Industries, Inc. (LXU) LSB Industries, Inc. (LXU) Eweakest fifth; percentile 87.3 NYSE · Industrial Inorganic Chemicals market equity $729.3M; last close $10.11 No active warnings; 12 of 14 inputs | 87.3 | E | |
| 285 | Liqtech International Inc. (LIQT) Liqtech International Inc. (LIQT) Eweakest fifth; percentile 87.4 Nasdaq · Misc Industrial & Commercial Machinery & Equipment market equity $14.8M; last close $0.47 No active warnings; 7 of 14 inputs | 87.4 | E | |
| 286 | CVR Partners, L.P. (UAN) CVR Partners, L.P. (UAN) Eweakest fifth; percentile 87.6 NYSE · Agricultural Chemicals market equity $1.3B; last close $125.71 No active warnings; 9 of 14 inputs | 87.6 | E | |
| 287 | Graphic Packaging Holding Co. (GPK) Graphic Packaging Holding Co. (GPK) Eweakest fifth; percentile 87.8 NYSE · Paperboard Containers & Boxes market equity $2.5B; last close $8.57 No active warnings; 9 of 14 inputs | 87.8 | E |
| Peer policy | Letter | Percentile | Peers |
|---|---|---|---|
| all graded filers, equal sleeves | E | 90.0 | 2204 |
| sector peers, equal sleeves (the grade) | E | 86.7 | 331 |
| same exchange, equal sleeves | E | 87.8 | 984 |
| sector peers, equal inputs | D/E | 78.2 | 331 |
Each letter is one fifth of the 331 graded peers, about 66 companies. A boundary letter (A/B, B/C, C/D, D/E) marks a percentile within one sampling error of a band edge.
What the Price Implies [top]
Market measures at the 2026-10-08 close. None enters the grade. Percentile among graded peers with the same measure.
| Measure | Value | Peer median | Percentile | Reading |
|---|---|---|---|---|
| Twelve-month price change, skipping the latest month | (59.5%) | 13.8% | 4 | hotter than 4 of 100 peers |
| Distance from 52-week high | (82.6%) | (24.2%) | 2 | closer to its high than 2 of 100 peers |
| EBIT to enterprise value | not computable | 3.9% | required accounting or market input is missing | |
| Free cash flow yield | (37.0%) | 3.2% | 3 | pricier than 97 of 100 peers |
| Book value to price | 1.86 | 0.39 | 96 | pricier than 4 of 100 peers |
| Sales to price | 4.34 | 0.57 | 96 | pricier than 4 of 100 peers |
| Composite equity issuance, five years | 434.9% | (9.9%) | 99 | more equity-funded than 99 of 100 peers |
| Relative strength against the sector, log excess return | (1.07) | (0.02) | 3 | ahead of 3 of 100 peers |
Inputs: market equity $4.4M; EBIT -$2.2M; free cash flow -$1.6M; book equity $8.2M; sales $19.2M; cash $2.1M[23].
Diagnostics [top]
Diagnostics do not feed the grade.
| Piotroski F-score: None of 9, period end 2025-09-30 | ||
|---|---|---|
| Return on assets above zero | (19.3%) | ✗ fail[4,6] |
| Operating cash flow above zero | -$1.5M | ✗ fail[5] |
| Return on assets improved | 3.6 pts | ✓ pass[4,6,21,24] |
| Operating cash flow exceeds net income | $588,527 | ✓ pass[4-5] |
| Long-term leverage fell | n/a[1,6,21] | |
| Current ratio improved | 131.0 pts | ✓ pass[15-16,25-26] |
| No new shares issued | n/a[27-28] | |
| Gross margin improved | 0.8 pts | ✓ pass[2-3,7-8] |
| Asset turnover improved | 61.1 pts | ✓ pass[2,6,8,21] |
Downloads [top]
|
Sources [top]
Every citation on this page. Filing opens the SEC index page for that submission; viewer opens the SEC interactive data for the same filing; series opens the SEC XBRL API record for that tag and company.
| # | Concept | XBRL tag | Value | Period end | Received | Form | Links |
|---|---|---|---|---|---|---|---|
| 1 | assets | us-gaap:Assets | $10.4M | 2025-09-30 | 2025-12-19 | 10-K | filing · viewer · series |
| 2 | revenue | us-gaap:Revenues | $19.2M | 2025-09-30 | 2025-12-19 | 10-K | filing · viewer · series |
| 3 | gross profit | us-gaap:GrossProfit | $12.0M | 2025-09-30 | 2025-12-19 | 10-K | filing · viewer · series |
| 4 | net income | us-gaap:NetIncomeLoss | -$2.0M | 2025-09-30 | 2025-12-19 | 10-K | filing · viewer · series |
| 5 | operating cash flow | us-gaap:NetCashProvidedByUsedInOperatingActivities | -$1.5M | 2025-09-30 | 2025-12-19 | 10-K | filing · viewer · series |
| 6 | assets | us-gaap:Assets | $10.6M | 2024-09-30 | 2025-12-19 | 10-K | filing · viewer · series |
| 7 | gross profit | us-gaap:GrossProfit | $12.0M | 2024-09-30 | 2025-12-19 | 10-K | filing · viewer · series |
| 8 | revenue | us-gaap:Revenues | $19.5M | 2024-09-30 | 2025-12-19 | 10-K | filing · viewer · series |
| 9 | gross profit | us-gaap:GrossProfit | $15.0M | 2023-09-30 | 2024-12-18 | 10-K | filing · viewer · series |
| 10 | revenue | us-gaap:Revenues | $24.2M | 2023-09-30 | 2024-12-18 | 10-K | filing · viewer · series |
| 11 | gross profit | us-gaap:GrossProfit | $22.3M | 2022-09-30 | 2023-12-22 | 10-K | filing · viewer · series |
| 12 | revenue | us-gaap:Revenues | $35.4M | 2022-09-30 | 2023-12-22 | 10-K | filing · viewer · series |
| 13 | gross profit | us-gaap:GrossProfit | $30.0M | 2021-09-30 | 2022-12-15 | 10-K | filing · viewer · series |
| 14 | revenue | us-gaap:Revenues | $44.5M | 2021-09-30 | 2022-12-15 | 10-K | filing · viewer · series |
| 15 | current assets | us-gaap:AssetsCurrent | $6.6M | 2025-09-30 | 2025-12-19 | 10-K | filing · viewer · series |
| 16 | current liabilities | us-gaap:LiabilitiesCurrent | $3.2M | 2025-09-30 | 2025-12-19 | 10-K | filing · viewer · series |
| 17 | retained earnings | us-gaap:RetainedEarningsAccumulatedDeficit | -$179.4M | 2025-09-30 | 2025-12-19 | 10-K | filing · viewer · series |
| 18 | operating income | us-gaap:OperatingIncomeLoss | -$2.2M | 2025-09-30 | 2025-12-19 | 10-K | filing · viewer · series |
| 19 | book equity | us-gaap:StockholdersEquity | $7.2M | 2025-09-30 | 2025-12-19 | 10-K | filing · viewer · series |
| 20 | liabilities | us-gaap:Liabilities | $3.2M | 2025-09-30 | 2025-12-19 | 10-K | filing · viewer · series |
| 21 | assets | us-gaap:Assets | $16.2M | 2023-09-30 | 2024-12-18 | 10-K | filing · viewer · series |
| 22 | assets | us-gaap:Assets | $40.8M | 2022-09-30 | 2023-12-22 | 10-K | filing · viewer · series |
| 23 | shares outstanding | dei:EntityCommonStockSharesOutstanding | 11,205,045 | 2026-08-13 | 2026-08-13 | 10-Q | filing · viewer · series |
| 24 | net income | us-gaap:NetIncomeLoss | -$3.7M | 2024-09-30 | 2025-12-19 | 10-K | filing · viewer · series |
| 25 | current assets | us-gaap:AssetsCurrent | $6.4M | 2024-09-30 | 2025-12-19 | 10-K | filing · viewer · series |
| 26 | current liabilities | us-gaap:LiabilitiesCurrent | $8.6M | 2024-09-30 | 2025-12-19 | 10-K | filing · viewer · series |
| 27 | shares outstanding | dei:EntityCommonStockSharesOutstanding | 10,495,561 | 2026-01-16 | 2026-01-20 | 10-K/A | filing · viewer · series |
| 28 | shares outstanding | dei:EntityCommonStockSharesOutstanding | 9,419,410 | 2025-12-16 | 2025-12-19 | 10-K | filing · viewer · series |
| 29 | cash | us-gaap:CashAndCashEquivalentsAtCarryingValue | $2.1M | 2026-06-30 | 2026-08-13 | 10-Q | filing · viewer · series |
| 30 | operating cash flow | us-gaap:NetCashProvidedByUsedInOperatingActivities | -$2.0M | 2026-06-30 | 2026-08-13 | 10-Q | filing · viewer · series |
| 31 | operating cash flow | us-gaap:NetCashProvidedByUsedInOperatingActivities | -$1.5M | 2026-03-31 | 2026-05-14 | 10-Q | filing · viewer · series |
| 32 | operating cash flow | us-gaap:NetCashProvidedByUsedInOperatingActivities | -$812,464 | 2025-12-31 | 2026-02-17 | 10-Q | filing · viewer · series |
| 33 | operating cash flow | us-gaap:NetCashProvidedByUsedInOperatingActivities | -$1.2M | 2025-06-30 | 2026-08-13 | 10-Q | filing · viewer · series |
Limitations [top]
Grade boundary. Percentile 86.7 is 6.7 points from the nearest band edge; sampling error is 2.7 points.
Peer group. Sector assignment from four-digit SIC codes, hand-tuned and published. The grade under three alternative peer policies is tabled above.
Size. Within a sector the letter tracks size. Among graded filers in the smallest asset band, 72% grade E and 0% grade A; in the largest, 13% grade E and 21% grade A. Universe as of Oct 9, 2026.
Failure model. filings 2012-01-01 to 2019-12-31 fit, filings 2020-01-01 to 2025-12-31 test; status post hoc pending confirmation. pre-registered on 2026 filings once their 12-month outcome windows close; supported if the paired per-quintile gain over the pooled model has a lower bound above 0.05.
Input validity. Revenue or total assets at or below $100,000 sets the degenerate-inputs flag. An input whose denominator is at or below $100,000 is left not computable rather than ranked.
Returns. No input on this page has a post-2015 confidence interval on returns that excludes zero. The grade ranks reported financial condition and is not a return forecast.
.jpg){kind=link}
.jpg){kind=link}
.jpg){kind=link}
.jpg){kind=link}
.jpg){kind=link}
.jpg){kind=link}
